Physiological and Psychological Effects of Music Therapy in the Pregnant Woman and Fetus
Launched by CHRISTINA CHIANIS REED · May 29, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how music therapy can help pregnant women who are hospitalized due to complications like preterm premature rupture of membranes (PPROM). The goal is to see if listening to music can help these mothers cope better with stress, bond with their unborn baby, and potentially extend their pregnancy. Although music therapy has been shown to benefit newborns and their caregivers after birth, this study is unique because it focuses on the effects of music therapy during pregnancy.
To be eligible for this trial, women must be between 18 and 64 years old, have a single baby (not twins or more), and be hospitalized for at least 48 hours due to the risk of premature delivery. Participants will be asked to listen to music during their hospital stay and attend follow-up visits after giving birth. If you or someone you know is interested in joining this study, it’s important to know that it aims to explore a new way to support pregnant women during a challenging time.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Pregnant women between 18 and 64 years of age.
- • 2. Singleton pregnancy.
- • 3. Hospital admission due to a high risk of premature delivery.
- • 4. Confirmed diagnosis of preterm premature rupture of membranes.
- • 5. Length of stay in the hospital for 48 hours or more and stable for 48 hours or more.
- • 6. Patients willing to listen to music.
- • 7. Patients willing to participate throughout all the music therapy sessions and the postpartum follow-up visit.
- Exclusion Criteria:
- • 1. Hospital length of stay of less than 48 hours.
- • 2. Non-singleton pregnancy Gravidae with severe medical and or surgical complications during their hospital admission that prevents them from participating in Music Therapy sessions.
About Christina Chianis Reed
Christina Chianis Reed is a dedicated clinical trial sponsor with a strong commitment to advancing medical research and improving patient outcomes. With extensive experience in the healthcare sector, she leads initiatives that prioritize innovation and adherence to regulatory standards. Her focus is on fostering collaborations among researchers, healthcare professionals, and regulatory bodies to facilitate the efficient execution of clinical trials. Under her guidance, the organization emphasizes ethical practices, patient safety, and the generation of robust clinical evidence to support the development of new therapies and interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Houston, Texas, United States
Patients applied
Trial Officials
Christina Reed, WHNP-BC
Principal Investigator
Baylor College of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported